首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
【2h】

Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate

机译:从木薯淀粉醋酸盐获得的控释药物传递系统的替代生物聚合物的九十天口服毒性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch acetate after oral exposure of Wistar rats for 90 days. The amount of food consumed and the body weight were weekly monitored. Blood and urine samples were obtained for the assessment of serum parameters and renal function. Histopathological analyses in target organs were also performed. No evidence of clinical toxicity in hematological, biochemical, or renal parameters in the FCSA-treated animals was found. In addition, relative organ weight and histopathological evaluations did not differ between groups treated with FCSA and control. Data obtained suggest that the subchronic exposure to FCSA does not cause obvious signs of toxicity in Wistar rats, indicating possible safety of this biofilm.
机译:木薯醋酸乙烯酯(FCSA)作为食品和药品中的成分而大量消耗的可生物降解薄膜需要评估这些产品的可能毒性。这项研究的目的是研究Wistar大鼠经口暴露90天后木薯淀粉醋酸盐可生物降解膜的毒性。每周监测食物消耗量和体重。获得血液和尿液样本以评估血清参数和肾功能。还对靶器官进行了组织病理学分析。在FCSA治疗的动物中,没有发现血液,生化或肾脏方面的临床毒性证据。此外,FCSA治疗组和对照组之间的相对器官重量和组织病理学评估没有差异。获得的数据表明,亚慢性暴露于FCSA不会在Wistar大鼠中引起明显的毒性迹象,表明该生物膜可能具有安全性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号